Treat to target in PsA should focus on clinical measures. Response to: 'DAPSA versus cDAPSA: do we need to use CRP?' by Gonçalves et al

Ann Rheum Dis. 2020 Nov;79(11):e143. doi: 10.1136/annrheumdis-2019-215990. Epub 2019 Jul 22.
No abstract available

Keywords: arthritis; psoriatic arthritis.

Publication types

  • Comment

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Psoriatic* / drug therapy
  • Cohort Studies
  • Humans
  • Remission Induction


  • Antirheumatic Agents